Author: Seer, Inc.

Posted Date:

May 13, 2026

Seer Reports First Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook

Seer, Inc.

May 13, 2026
Seer Files Patent Infringement Lawsuit Against Nanomics

Seer, Inc.

May 13, 2026
Seer Announces Appointment of Anthony Bazarko as Chief Commercial Officer

Seer, Inc.

May 8, 2026
Seer to Report First Quarter 2026 Financial Results on May 13, 2026

Seer, Inc.

May 7, 2026
Seer Board of Directors Unanimously Rejects Revised Unsolicited Proposal from Radoff-JEC Group

Seer, Inc.

May 7, 2026
Seer Confirms Receipt of Unsolicited Proposal and Director Candidate Nominations from Radoff-JEC Group

Seer, Inc.

May 5, 2026
Seer and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 PRECISE SG100K Samples

Seer, Inc.

May 5, 2026
Patent Board Upholds Seer’s Nano and Micro Particle Protein Enrichment Patent in a Challenge by Bruker Subsidiaries

Seer, Inc.

May 4, 2026
Seer Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Outlook

Seer, Inc.

April 30, 2026
Seer Adopts Limited Duration Tax Benefit Preservation Plan to Protect its Valuable Tax Assets

Seer, Inc.

April 30, 2026